ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• From Regulators To PUPSIT: Notes On Annex 1 Revision Implementation

  Kevin Smyth, a biochemical engineer with 30 years of experience in the pharmaceutical industry, offers insights and expertise in working with firms to understand what regulators seek to meet new standards.

• White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges

  Explore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.

• The Importance Of Strategic Alliance Partners In Biopharmaceuticals

  Today’s drug delivery systems are complex technologies that require close teamwork between biopharmaceutical companies and their drug delivery technology partners to develop innovative platforms.

• Transitioning From A Vial To PFS Or Cartridge In An Auto-Injector Device

  Explore how to approach the transition of migrating from a vial to a syringe or cartridge, the necessary compatibility testing, and the stresses on the bulk product during formulation and filling.

• Leveraging Integration At Each Phase Of A Drug Delivery System Project

  By forging deeper partnerships with customers, the full depth and breadth of our knowledge, experience and competencies can bring benefits at multiple levels. See how an integrated offering helps at each phase of a drug delivery system project.

• Data-Driven Innovation Is Drug Delivery's Next Evolution

  To mitigate inherent risks like inconsistent dosing, user error, and low adoption due to complex usage procedures, technological innovation in delivery devices is best guided by lessons from the past, including user feedback and follow-on learnings from market data.

• Navigating PFAS In Medical Devices

  Review how an experienced partner can help you navigate the shifting regulatory landscape for your medical device.

• Solid Form Strategies For Increasing Oral Bioavailability

  Optimizing a drug’s solid form can improve its solubility and bioavailability when further molecular modifications are prohibitive.

• Autoinjectors: A Revolutionary Leap In Drug Delivery

  Explore how the widespread adoption of autoinjectors is transforming the biopharmaceutical industry's approach to drug delivery, offering precise dosing, patient adherence, and safety.

• Leachables Method Development, Validation And Relevant ICH References

  It is crucial to develop and validate analytical methods capable of detecting a wide range of potential organic and inorganic leachables specific to the drug and its packaging.